✦ LIBER ✦

Clinical significance of urinary Monocyte Chemoattractant Protein-1 (uMCP-1) in Indian type 2 diabetic patients at different stages of diabetic nephropathy

✍ Scribed by Priyanka Tilak; Zenith Khashim; Satyavani Kumpatla; Mary Babu; Vijay Viswanathan

Book ID: 113643808
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 106 KB
Volume: 2
Category: Article
ISSN: 1877-5934
DOI: 10.1016/j.ijdm.2009.10.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance and different leve

Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in Type 2 diabetes mellitus

✍ Wang Qiu-yue; Chen Fen-qin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Urinary levels of monocyte chemoattracta

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy

✍ Kyouichi Tashiro; Ichiro Koyanagi; Akemi Saitoh; Ayumi Shimizu; Toshihide Shike; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

## Abstract We examined the correlation among the levels of urinary monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), hyperglycemia, and renal injuries in patients with type 2 diabetic nephropathy. The levels of urinary MCP‐1, IL‐8, protein excretion, blood urea nitrogen (BUN), s

Urinary excretion of retinol-binding pro

Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy

✍ P. Pontuch; T. Jensen; T. Deckert; P. Ondrejka; M. Mikulecky 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 478 KB

Urinary TGF-β1 reduction related to a de

Urinary TGF-β1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy

✍ Marcello Casaccia Bertoluci; Deise Uebel; Alexandre Schmidt; Fulvio Clemo Santos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 291 KB

The effect of low-dose atorvastatin on c

The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein–1 in patients with type 2 diabetes complicated by hyperlipidemia

✍ Kohzo Takebayashi; Sachiko Matsumoto; Sadao Wakabayashi; Yoshihisa Inukai; Rika 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Circulating advanced glycation end produ

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes

✍ Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Takanori Matsui; Yayoi Kurit 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views